Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 13151 - 13175 of 14813 in total
4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
Matched Iupac: … 1-(2-methoxy-5-methylphenyl)-3-[6-({6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl}amino …
Matched Description: … 4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia. …
GSK690693 has been used in trials studying the treatment of Tumor, CANCER, and Lymphoma.
Investigational
Matched Iupac: … 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-piperidin-3-yl]methoxy}-1H-imidazo[4,5-c]pyridin …
Matched Description: … GSK690693 has been used in trials studying the treatment of Tumor, CANCER, and Lymphoma. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Tetrasul has been used in trials studying the treatment of Erythematous (Type One) Rosacea.
Investigational
Matched Description: … Tetrasul has been used in trials studying the treatment of Erythematous (Type One) Rosacea. …
Diethylhomospermine has been used in trials studying the treatment of Diarrhea and HIV Infections.
Investigational
Matched Description: … Diethylhomospermine has been used in trials studying the treatment of Diarrhea and HIV Infections. …
Navarixin has been investigated for the treatment of Asthma.
Investigational
Matched Iupac: … 2-hydroxy-N,N-dimethyl-3-[(2-{[(1R)-1-(5-methylfuran-2-yl)butyl]amino}-3,4-dioxocyclobut-1-en-1-yl)amino …
Matched Description: … Navarixin has been investigated for the treatment of Asthma. …
Parsatuzumab is under investigation in clinical trial NCT01366131 (Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)).
Investigational
Matched Description: … of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or ... Parsatuzumab is under investigation in clinical trial NCT01366131 (Study Evaluating the Safety and Efficacy …
Experimental
Varespladib methyl has been investigated for the treatment of Acute Coronary Syndrome. Studies showed that Varespladib methyl treatment resulted in significant positive changes on lipoproteins and inflammation.
Investigational
Matched Iupac: … methyl 2-{[1-benzyl-3-(carbamoylcarbonyl)-2-ethyl-1H-indol-4-yl]oxy}acetate …
Matched Description: … Varespladib methyl has been investigated for the treatment of Acute Coronary Syndrome. ... Studies showed that Varespladib methyl treatment resulted in significant positive changes on lipoproteins …
Benzbromarone has been used in trials studying the basic science and treatment of Heart Failure, Hyperuricemia, Chronic Kidney Disease, Abnormal Renal Function, and Gout and Asymptomatic Hyperuricemia.
Investigational
Withdrawn
Matched Iupac: … 2,6-dibromo-4-(2-ethyl-1-benzofuran-3-carbonyl)phenol …
Matched Description: … Benzbromarone has been used in trials studying the basic science and treatment of Heart Failure, Hyperuricemia …
Idasanutlin has been used in trials studying the treatment of Neoplasms, Non-Hodgkin's Lymphoma, Leukemia, Myeloid, Acute, Recurrent Plasma Cell Myeloma, and Neoplasms, Leukemia, Acute Myeloid Leukemia.
Investigational
Matched Description: … Idasanutlin has been used in trials studying the treatment of Neoplasms, Non-Hodgkin's Lymphoma, Leukemia …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
NOX-700, an new orally active dithiocarbamate-based nitric oxide (NO) blocking agent that is in development for the treatment of diabetes mellitus (type 2 diabetes). In animal studies, NOX-700 lowered serum glucose, improved glucose tolerance, and reduced the percentage of total glycated hemoglobin. Immunohistochemical studies on pancreatic tissue also showed that...
Investigational
Matched Description: … It has since been found that oxidative signaling of the redox-sensitive transcription factor, NF-κB, ... for the treatment of diabetes mellitus (type 2 diabetes). ... In animal studies, NOX-700 lowered serum glucose, improved glucose tolerance, and reduced the percentage …
Tiragolumab is under investigation in clinical trial NCT04513925 (A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)).
Investigational
Matched Description: … Tiragolumab is under investigation in clinical trial NCT04513925 (A Study of Atezolizumab and Tiragolumab ... Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-small Cell …
2-(5-fluoro-pentyl)-2-methyl-malonic-acid is under investigation in clinical trial NCT00696943 (18F ML-10 for Early Detection of Response of Brain Metastases to SRS).
Investigational
Matched Description: … -10 for Early Detection of Response of Brain Metastases to SRS). ... 2-(5-fluoro-pentyl)-2-methyl-malonic-acid is under investigation in clinical trial NCT00696943 (18F ML …
Experimental
Matched Iupac: … amino]-3-(4-hydroxyphenyl)propan-1-one ... (2S)-2-amino-1-[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}sulfonyl) …
Zidebactam is under investigation in clinical trial NCT02674347 (MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults).
Investigational
Matched Description: … and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults). ... Zidebactam is under investigation in clinical trial NCT02674347 (MAD Study to Evaluate the Safety, Tolerability …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Osocimab is under investigation in clinical trial NCT03276143 (Factor XIa inhibition for the prevention of venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty).
Investigational
Matched Description: … of venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty). ... Osocimab is under investigation in clinical trial NCT03276143 (Factor XIa inhibition for the prevention …
Proxalutamide is under investigation in clinical trial NCT03899467 (The Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer).
Investigational
Matched Iupac: … 4-(4,4-dimethyl-3-{6-[3-(1,3-oxazol-2-yl)propyl]pyridin-3-yl}-5-oxo-2-sulfanylideneimidazolidin-1-yl) …
Matched Description: … Proxalutamide is under investigation in clinical trial NCT03899467 (The Safety and Tolerability of Proxalutamide ... (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer). …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
CA4P has been shown in the laboratory to shut down the blood supply to tumours. It is one of the first vascular targeting drugs to be tested in patients. This drug was originally isolated from the African Bush Willow. The first studies in patients with this drug were aimed at...
Investigational
Matched Description: … It is one of the first vascular targeting drugs to be tested in patients. ... CA4P has been shown in the laboratory to shut down the blood supply to tumours. ... The first studies in patients with this drug were aimed at finding out whether it can be safely given …
Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.
Investigational
Matched Description: … Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Ipa has been used in trials studying the treatment of Nausea and Surgical Site Infection.
Investigational
Matched Iupac: … (2R,3S,4R,5R)-2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxolane-3,4-diol …
Matched Description: … Ipa has been used in trials studying the treatment of Nausea and Surgical Site Infection. …
Displaying drugs 13151 - 13175 of 14813 in total